JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.
April 2023 Case of the Month
Sign in to Google
to save your progress.
Learn more
* Indicates required question
Email
*
Your email
Name
*
Your answer
Email Address
*
Your answer
1.) What is the correct immunohistochemical staining profile of a benign dermatofibroma (DF)?
*
actor XIIIa+, CD34+
Factor XIIIa+, CD34-
Factor XIIIa-, CD34+
Factor XIIIa-, CD34-
2.) According to the ACMS (American College of Mohs Surgery) Appropriate Use Criteria (AUC), what is the preferred treatment modality for a 2.0 cm primary invasive squamous cell carcinoma without aggressive histologic features on the pretibial shin in an otherwise healthy individual?
*
Wide local excision
Mohs micrographic surgery
Destruction via shave removal plus cryosurgery/electrodessication and curettage
5-Fluorouracil BID x6 weeks
Submit
Clear form
Never submit passwords through Google Forms.
This form was created inside of C2C Association Management Solutions.
Report Abuse
Forms
